Facebook
Twitter
Telegram
Report an ErrorEnlivex Therapeutics Ltd. Financial Statements 2011-2024 | ENLV
Annual Financial Statements Enlivex Therapeutics Ltd.
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
46.2 M | 115 M | 123 M | 72.6 M | 21.7 M | 62.7 M | 16.6 M | 52.1 M | 99.9 M | - | - | - |
Shares |
18.4 M | 18.3 M | 14.6 M | 8.65 M | 3.51 M | 3.43 M | 399 K | 356 K | 306 K | - | - | - |
Historical Prices |
2.51 | 6.25 | 8.43 | 8.39 | 6.19 | 18.3 | 41.6 | 155 | 256 | - | - | - |
Net Income |
-31.1 M | -14.5 M | -11.8 M | -9.38 M | -4.24 M | -2.5 M | -16 M | -15.4 M | -7.02 M | -1.14 M | -229 K | - |
Revenue |
- | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
- | - | 737 K | 569 K | 525 K | 365 K | 373 K | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-25.8 M | -19.3 M | -9.78 M | -8.62 M | -5.3 M | -2.17 M | -15.9 M | -15.5 M | -7.08 M | -1.15 M | -226 K | - |
Interest Expense |
-5.26 M | 4.82 M | -2.04 M | -765 K | -4 K | 38 K | 60 K | - | - | - | - | - |
EBITDA |
- | -18.7 M | -9.5 M | -8.41 M | -5.18 M | -2.09 M | -15.8 M | -15.5 M | -7.08 M | -1.14 M | -226 K | - |
Operating Expenses |
- | 19.3 M | - | 8.62 M | 5.3 M | 5.96 M | 15.9 M | 15.5 M | 7.08 M | - | - | - |
General and Administrative Expenses |
7.1 M | 6.41 M | 3.7 M | 3.02 M | 96 K | 16 K | 5.9 M | 6.95 M | 2.64 M | 416 K | - | - |
All numbers in USD currency
Quarterly Income Statement Enlivex Therapeutics Ltd.
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
- | - | - | - | 18.3 M | - | 18.3 M | - | 14.6 M | - | 13.4 M | - | 10.3 M | - | 10.1 M | - | 3.51 M | - | - | - | 418 K | - | - | - | 3.28 M | - | - | - | 14.2 M | - | - | - | 14.2 M | - | - | - | 9.18 M | - | - | - | - | - | - | - | - | - | - | - |
Net Income |
- | - | - | - | - | - | -3.11 M | - | - | - | -3.04 M | - | - | - | -1.46 M | - | - | - | - | - | - | - | - | - | -3.07 M | -4.67 M | -3.68 M | -4.59 M | -4.83 M | -3.55 M | -3.69 M | -3.3 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
- | - | - | - | - | - | -3.81 M | - | - | - | -2.23 M | - | - | - | -1.3 M | - | - | - | - | - | - | - | - | - | -3.07 M | -4.58 M | -3.72 M | -4.49 M | -4.83 M | -3.59 M | -3.74 M | -3.32 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Interest Expense |
- | - | - | - | - | - | 700 K | - | - | - | -808 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA |
- | - | - | - | - | - | -3.69 M | - | - | - | -2.17 M | - | - | - | -1.2 M | - | - | - | - | - | - | - | - | - | -3.07 M | -4.58 M | -3.72 M | -4.49 M | -4.83 M | -3.59 M | -3.74 M | -3.32 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Expenses |
- | - | - | - | - | - | 3.81 M | - | - | - | 2.23 M | - | - | - | 1.3 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
- | - | - | - | - | - | 1.27 M | - | - | - | 976 K | - | - | - | 601 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency